Agency Report/
The first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle, US health officials said on Monday.
“The open-label trial will enrol 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,” the US National Institutes of Health said in a statement.
“The first participant received the investigational vaccine today.”
*AFP
0Femi Ashekun/ Handheld walkie-talkies used by Hizbollah were detonated across Lebanon today, the militant group…
… Identifies Challenges and Solutions for Humanitarian Interventions In an exclusive interview, Mohamed Malick Fall,…
Segun Atanda/ In a nationwide crackdown on crime, the Nigeria Police Force has arrested 2,740…
Segun Atanda/ Former Lagos State Commissioner of Police, Adegoke Fayoade, officially handed over to his…
By Ifeanyi Igwebike Mbanefo/ On 17 September 2016, I was scrolling through Cable online news…
Matilda Omonaiye/ The FBI is investigating another apparent assassination attempt on former President Donald Trump…